ENLV · Enlivex Ltd. · Documents
Market Cap
$4.45M
Shares
19.91M
Volume · Oct 21
745.4K
Avg daily vol (3M)
1.05M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | Enlivex announced a cost reduction plan on October 19, 2026, cutting its workforce by approximately 60%, winding down non-clinical R&D, and reducing management salaries by 20% and the CEO's by 40% to fund its Phase 2b Allocetra™ knee osteoarthritis trial, with topline data expected by mid-2027. | 2026-10-19 | — | |
| 6-K/A | — | 2026-10-02 | — | |
| 6-K/A | — | 2026-10-01 | 2026-09-30 | |
| 6-K | — | 2026-09-29 | — | |
| 6-K | — | 2026-09-25 | 2026-06-30 | |
| 6-K | — | 2026-09-22 | — | |
| 6-K | — | 2026-08-11 | — | |
| F-3 | — | 2026-08-06 | — | |
| 6-K | — | 2026-07-30 | — | |
| 6-K | — | 2026-07-29 | — | |
| 6-K | — | 2026-07-28 | — | |
| 6-K | — | 2026-07-28 | — | |
| 6-K | — | 2026-07-20 | — | |
| 6-K | — | 2026-07-13 | — | |
| 6-K | — | 2026-07-07 | — | |
| 6-K | — | 2026-06-24 | — | |
| 6-K | — | 2026-06-22 | — | |
| 6-K | — | 2026-05-28 | — | |
| 6-K | — | 2026-05-27 | — | |
| 6-K | — | 2026-05-18 | — | |
| 6-K | — | 2026-05-15 | — | |
| 6-K | — | 2026-04-21 | — | |
| F-3 | — | 2026-04-21 | — | |
| 6-K | — | 2026-04-08 | — | |
| 6-K | — | 2026-03-26 | — | |
| 6-K | — | 2026-03-25 | — | |
| 20-F | — | 2026-03-25 | 2025-12-31 | |
| 6-K | — | 2026-03-24 | — | |
| 6-K | — | 2026-03-23 | — | |
| 6-K | — | 2026-02-23 | — | |
| 6-K | — | 2026-02-10 | — | |
| 6-K | — | 2026-02-05 | — | |
| 6-K | — | 2026-01-26 | — | |
| 6-K | — | 2026-01-23 | — | |
| 6-K | — | 2026-01-07 | — | |
| F-3 | — | 2025-12-23 | — | |
| 6-K | — | 2025-12-18 | — | |
| 6-K | — | 2025-12-04 | — | |
| 6-K | — | 2025-11-26 | — | |
| 6-K | — | 2025-11-24 | — | |
| 6-K | — | 2025-11-24 | — | |
| 6-K | — | 2025-11-18 | — | |
| 6-K | — | 2025-11-14 | — | |
| 6-K | — | 2025-11-10 | — | |
| 6-K | — | 2025-09-25 | — | |
| 6-K | — | 2025-09-11 | — | |
| 6-K | — | 2025-09-09 | — | |
| 6-K | — | 2025-08-29 | 2025-06-30 | |
| 6-K | — | 2025-08-18 | — | |
| 6-K | — | 2025-08-18 | — |
Showing 1–50 of 210 filings